Comprehensive Pharmacist Patient Assessment, Prescribing, and Billing for Oregon's Tobacco Cessation Implementation:

In Oregon, more than 6 out of 10 people who smoke cigarettes want to quit. Most people who smoke have attempted to quit in the past year. Smoking is the leading preventable cause of death and disease in Oregon, killing nearly 8,000 people every year. Pharmacists in Oregon will make an impact on Oregon’s tobacco cessation endeavors. During the novel coronavirus pandemic, cigarette smoking has been linked to increased risk of severe COVID-19, including hospitalization and death.

Oregon State University College of Pharmacy, in partnership with the Public Health Division of the Oregon Health Authority, has led the creation of this training, which exceeds all requirements set forth by the Oregon Board of Pharmacy for approved training for tobacco cessation prescribing. The course is uniquely designed to educate the Oregon pharmacist on assessing and prescribing tobacco cessation medications based upon the Oregon Board of Pharmacy’s Public Health and Pharmacy Formulary Advisory Committee guidelines. The training is authored by the subject matter experts who were engaged in advising the PHPFAC and OBOP to create the Tobacco Cessation Patient Intake Form and Tobacco Cessation Assessment and Treatment Care Pathway.

The Oregon Health Authority – Public Health Division (OHA-PHD) and the Health Promotion and Chronic Disease Prevention Section (HPCDP) provided funding to the Oregon State University College of Pharmacy to educate and train pharmacists to treat nicotine addiction.

Accreditation Council for Pharmacy Education Information:

This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Statement of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules 3) Passing a final exam with 80% or higher and 4) Completion of the program evaluation.

At the completion of this activity, the participant will be able to:
1) Discuss the epidemiology and burden of tobacco use
2) Recognize the different types of tobacco products and electronic nicotine delivery systems (ENDS) people use, and how they are often used together
3) List the different FDA approved medications to help with tobacco cessation and combination use
4) Describe possible side effects of FDA-approved medications for tobacco cessation
5) Counsel patients on how to use FDA-approved medications for tobacco cessation
6) Apply the 5As approach during a pharmacist-provided tobacco cessation visit
7) Analyze and discuss the questions on the "Tobacco Cessation Self-Screening Patient Intake Form"
8) Utilize the "Tobacco Cessation Assessment and Treatment Care Pathway" during a pharmacist-provided tobacco cessation visit in order to apply a patient care process to prescribing tobacco cessation medications
9) List the elements in a tobacco cessation follow up, per Oregon's requirements
10) Document a tobacco cessation visit, per Oregon's assessment and prescribing requirements
11) List and discuss five resources the Oregon Health Authority's Tobacco Prevention and Education Program recommends for assisting Oregon patients attempting to quit smoking
12) Describe the billing guidelines for the pharmacist-led patient assessment

UAN: 0036-0000-20-055-H01-P
Target Audience: Pharmacists licensed in Oregon
Activity Type: Application
Activity Release Date: 11/01/2020
Activity Expiration Date: 11/01/2023
Faculty/Contributors: 
Julianne Himstreet, PharmD, BCPS, Adjunct Faculty, Oregon State University College of Pharmacy
Kiyomi Lehman, PharmD, BCPS, BCACP, Clinical Ambulatory Care Pharmacist, Mosaic Medical
Hilde Hinkel, MPH, Health Promotion Strategist, Oregon Health Authority
Sarah Hargand, MPH, Oregon Health Authority
Sarah Wylie, MPH, Health Promotion Strategist, Oregon Health Authority
Rebecca Garza, MS, Health Promotion Strategist, Oregon Health Authority
Derek Smith, MSW, MPH, Tobacco Policy Specialist, Oregon Health Authority
Paige Clark, RPh, BPharm
Sharon Rask, RPh, BPharm
Disclosures: None of the faculty, designers, or reviewers for this course have any relationships with ineligible to disclose.